Case Study

Clinical Cornerstone

Volumn 9, Issue SUPPL. 3, 2009, Pages

  Quan, Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GLUCOSE; HYDROCHLOROTHIAZIDE; LISINOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANAMNESIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; DIET THERAPY; DRUG DOSE TITRATION; EXERCISE; HUMAN; HYPERTENSION; LIP DISEASE; LIP SWELLING; LOW DRUG DOSE; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; WAIST CIRCUMFERENCE; ANGIONEUROTIC EDEMA; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED;

ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 65349110291     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(09)60017-X     Document Type: Article

References (14)

1. Cherry D.K., Woodwell D.A., and Rechtsteiner E.A. National Ambulatory Medical Care Survey: 2005 Summary. Adv Data 29 (2007) 1-39
2. Chobanian A.V., Bakris G.L., Black H.R., et al., for the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
3. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 31 Suppl 1 (2008) S12-S54
4. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
5. Rosendorff C., Black H.R., Cannon C.P., et al. Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115 (2007) 2761-2788
6. IMS Health Reports. http://www.imshealth.com/portal/site/imshealth/menuitem Accessed December 9, 2008.
7. Israili Z.H., and Hall W.D. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 117 (1992) 234-242
8. Matchar D.B., McCrory D.C., Orlando L.A., et al. Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 148 (2008) 16-29
9. Nussberger J., Cugno M., and Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 347 (2002) 621-622
10. Kostis J.B., Kim H.J., Rusnak J., et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 165 (2005) 1637-1642
11. Cicardi M., Zingale L.C., Bergamaschini L., and Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: Outcome after switching to a different treatment. Arch Intern Med 164 (2004) 910-913
12. Miller D.R., Oliveria S.A., Berlowitz D.R., et al. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 51 (2008) 1624-1630
13. Kaplan A.P. Clinical practice: Chronic urticaria and angioedema. N Engl J Med 346 (2002) 175-179
14. Abdi R., Dong V.M., Lee C.J., and Ntoso K.A. Angiotensin II receptor blocker-associated angioedema: On the heels of ACE inhibitor angioedema. Pharmacotherapy 22 (2002) 1173-1175